{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__94__00470-Z.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__94__00470-Z.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__94__00470-Z.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (IC50)"]], "doi": "10.1016/0960-894X(94)00470-Z", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00091-7.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00091-7.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00091-7.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (EC50)"], ["Affinities", "5-HT1A (Ki)"]], "doi": "10.1016/0960-894X(95)00091-7", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00133-E.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00133-E.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00133-E.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "Cytotoxicity in 2.2.15 Cells (IC50)"], ["Affinities", "Anti-HBV Activity in 2.2.15 Cells (EC50)"]], "doi": "10.1016/0960-894X(95)00133-E", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00251-N.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00251-N.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00251-N.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "In vitro anticancer activity against 11 NCI NSCLC cell lines (Activity)"], ["Affinities", "CCRF-CEM (GI50)"], ["Affinities", "HL-60 (TB) (GI50)"], ["Affinities", "K-562 (GI50)"], ["Affinities", "MOLT-4 (GI50)"], ["Affinities", "RPMI-8226 (GI50)"], ["Affinities", "SR (GI50)"]], "doi": "10.1016/0960-894X(95)00251-N", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00358-Z.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00358-Z.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00358-Z.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT4 (pKb)"]], "doi": "10.1016/0960-894X(95)00358-Z", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00417-R.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00417-R.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00417-R.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (EC50)"]], "doi": "10.1016/0960-894X(95)00417-R", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__95__00473-7.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__95__00473-7.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__95__00473-7.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (pIC50)"]], "doi": "10.1016/0960-894X(95)00473-7", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__96__00293-4.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__96__00293-4.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__96__00293-4.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "Anti-HIV-1 Activities to PBM Cells (EC50)"], ["Affinities", "Anti-HIV-1 Activities to PBM Cells (EC50)"], ["Affinities", "Anti-HIV-1 Activities to PBM Cells (IC50)"], ["Affinities", "Anti-HIV-1 Activities to CEM Cells (EC50)"], ["Affinities", "Anti-HIV-1 Activities to CEM Cells (IC50)"], ["Affinities", "Anti-HBV Activities to 2.2.15 Cells (EC50)"], ["Affinities", "Anti-HBV Activities to 2.2.15 Cells (IC50)"]], "doi": "10.1016/0960-894X(96)00293-4", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_0960-894X__96__00324-1.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_0960-894X__96__00324-1.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_0960-894X__96__00324-1.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (IC50)"]], "doi": "10.1016/0960-894X(96)00324-1", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_j.bmcl.2003.09.002.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_j.bmcl.2003.09.002.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_j.bmcl.2003.09.002.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "5-HT1A (Emax)"], ["Affinities", "5-HT1A (Ki)"]], "doi": "10.1016/j.bmcl.2003.09.002", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1007_s00044-005-0126-y.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1007_s00044-005-0126-y.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1007_s00044-005-0126-y.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "Falcipain 2 (IC50)"]], "doi": "10.1007/s00044-005-0126-y", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1007_s00044-011-9818-7.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1007_s00044-011-9818-7.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1007_s00044-011-9818-7.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "PPAR-\u03b3 (EC50)"]], "doi": "10.1007/s00044-011-9818-7", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_j.ejmech.2016.04.051.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_j.ejmech.2016.04.051.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_j.ejmech.2016.04.051.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "A2780 (EC50)"]], "doi": "10.1016/j.ejmech.2016.04.051", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_j.tet.2004.09.011.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_j.tet.2004.09.011.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_j.tet.2004.09.011.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "NADH oxidase chain 1 (IC50)"]], "doi": "10.1016/j.tet.2004.09.011", "pages": [1, -1]}
{"file_name": "SciAssess_library/DrugDiscovery/10.1016_s0960-894x__01__00004-x.pdf", "answerfile_name": "SciAssess_library/csv/DrugDiscovery/10.1016_s0960-894x__01__00004-x.csv", "answerfile_link": "https://dp-filetrans-bj.oss-cn-beijing.aliyuncs.com/changjunhan/10.1016_s0960-894x__01__00004-x.csv", "compare_fields": ["Compound", "SMILES", ["Affinities", "Prostaglandin COX-1 (IC50)"]], "doi": "10.1016/s0960-894x(01)00004-x", "pages": [1, -1]}
